An announcement from Anagenics ( (AU:AN1) ) is now available.
Anagenics Limited has announced its business strategy and objectives following a restructuring program aimed at simplifying its business structure and achieving sustainable earnings. The company plans to focus on organic growth by enhancing the profitability of its BLC Cosmetics business and expanding its owned products division with new brands and reinforced royalty income streams. Additionally, Anagenics is pursuing acquisitive growth through potential accretive acquisitions. The company believes it has sufficient funds to support its operations over the next two quarters without requiring additional equity funding, although it remains open to raising new debt or equity capital if value accretive opportunities arise.
More about Anagenics
Anagenics Limited is a company operating in the health, beauty, and wellness industry, focusing on the global distribution and sales of proprietary and licensed brands of differentiated, clinically validated anti-aging solutions. The company operates through two main divisions: BLC Cosmetics, a wholly owned subsidiary dedicated to the sales and distribution of leading Australian and international cosmetic and wellness brands, and its owned products division, which includes in-house developed beauty and hair product brands.
Current Market Cap: A$3.69M
Find detailed analytics on AN1 stock on TipRanks’ Stock Analysis page.